InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: MinnieM post# 179284

Thursday, 04/20/2017 9:21:18 PM

Thursday, April 20, 2017 9:21:18 PM

Post# of 403738
You are the best KarinCA! Thanks. So I agree this is just good for new investors and also for interested parties and just simple PR to get new investors excited about the Anti-Inflammatory properties of B. It is a possible branch of B that could be extremely lucrative and in the short term especially if B-OM keeps up the numbers. As Leo said they will go for FAST TRACK if the numbers keep pace.

I have listened to the presentation acouple times today and just looked over the slides for the first time just now. Here are a couple things that I did not know:

Additional research is underway to determine B's role in regulating IL-17>

B-OM - onset for B with greater than 3WHO - 45 days for the 2 patients
onset for 7 patients using placebo was 29 days.... so even for the 2 patients taking B it appears that it is still beneficial as it gives the patient 16 more days to eat or have less pain :)

How did they decide on 45 mg of B for OM? Why not a second arm with a different dose to help optimize the next phase 3? Just curious

Increased potential for Atopic Dermatitis, Hidradentis suppurativa, Acne
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News